New and revised gene ontology biological process terms describe multiorganism interactions critical for understanding microbial pathogenesis and sequences of concern.

Publication date: Mar 21, 2025

There is a new framework from the United States government for screening synthetic nucleic acids. Beginning in October of 2026, it calls for the screening of sequences 50 nucleotides or greater in length that are known to contribute to pathogenicity or toxicity for humans, regardless of the taxa from which it originates. Distinguishing sequences that encode pathogenic and toxic functions from those that lack them is not simple. Our project scope was to discern, describe, and catalog sequences involved in microbial pathogenesis from the scientific literature. We recognize a need for better terminology to designate pathogenic functions that are relevant across the entire range of existing parasites. We canvassed publications investigating microbial pathogens of humans, other animals, and some plants to collect thousands of sequences that enable the exploitation of hosts. We compared sequences to each other, grouping them according to what host biological processes they subvert and the consequence(s) for the host. We developed terms to capture many of the varied pathogenic functions for sequences employed by parasitic microbes for host exploitation and applied these terms in a systematic manner to our dataset of sequences. The enhanced and expanded terms enable a quick and pertinent evaluation of a sequence’s ability to endow a microbe with pathogenic function when they are appropriately applied to relevant sequences. This will allow providers of synthetic nucleic acids to rapidly assess sequences ordered by their customers for pathogenic capacity. This will help fulfill the new US government guidance.

Open Access PDF

Concepts Keywords
Biomed Animals
Expanded Controlled vocabularies
Host Gene Ontology
Pathogenicity Humans
Infectious diseases
Microbial pathogenesis
Ontologies
Synthetic nucleotide screening
Terminology as Topic

Semantics

Type Source Name
disease MESH pathogenesis
drug DRUGBANK Tropicamide
disease MESH Infectious diseases
drug DRUGBANK Coenzyme M
drug DRUGBANK Trestolone
disease MESH death
disease MESH inflammation
drug DRUGBANK Adenosine phosphate
drug DRUGBANK Cyclic Adenosine Monophosphate
disease MESH tumor
disease MESH necrosis
drug DRUGBANK Oxygen
drug DRUGBANK Cholesterol
disease MESH infection
drug DRUGBANK Nordazepam

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *